Simultaneous determination of ginsenoside Rb1 and Rg1 in human plasma by liquid chromatography-mass spectrometry

被引:43
作者
Ji, HY
Lee, HW
Kim, HK
Kim, HH
Chang, SG
Sohn, DH
Kim, J
Lee, HS
机构
[1] Wonkwang Univ, Coll Pharm, Iksan 570749, South Korea
[2] Wonpharm Co Ltd, Iksan 570950, South Korea
关键词
ginsenoside Rb-1; ginsenoside Rg(1); LC/MS; plasma;
D O I
10.1016/j.jpba.2003.12.020
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A liquid chromatographic-mass spectrometric (LOMS) method for the simultaneous determination of ginsenoside Rb, and Rg(1) in human plasma was developed. The method involved the protein precipitation followed by analysis of ginsenoside Rb, and Rg(1) in an Atlantis C-18 column with the gradient elution of acetonitrile and ammonium formate (10 mM, pH 3.0) at a flow rate of 0.2 ml/min. The analytes were determined using electrospray negative ionization mass spectrometry in the selected ion monitoring mode. The standard curves for ginsenoside Rb-1 and Rg(1) were linear over the concentration range of 10.0-1000 ng/ml. The lower limit of quantification was 10.0 ng/ml using 100 mul plasma sample. The coefficient of variation of intra- and inter-day assays for ginsenoside Rb-1 and Rg(1) at three quality control levels ranged from 1.0 to 6.8% and 5.4 to 9.8%, respectively. Ginsenoside Rb, and Rg(1) were stable in blank human plasma at room temperature for 24 h and following three freeze-thaw cycles. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 14 条
[1]   Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng [J].
Akao, T ;
Kida, H ;
Kanaoka, M ;
Hattori, M ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) :1155-1160
[2]  
[Anonymous], 2001, Guidance for industry, bioanalytical method validation
[3]   Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[4]   Gas chromatographic-mass spectrometric determination of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol for study on human urinary excretion of ginsenosides after ingestion of ginseng preparations [J].
Cui, JF ;
Bjorkhem, I ;
Eneroth, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1997, 689 (02) :349-355
[5]   Panax ginseng pharmacology: A nitric oxide link? [J].
Gillis, CN .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) :1-8
[6]   Main Ginseng saponin metabolites formed by intestinal bacteria [J].
Hasegawa, H ;
Sung, JH ;
Matsumiya, S ;
Uchiyama, M .
PLANTA MEDICA, 1996, 62 (05) :453-457
[7]  
KAKIKURA M, 1991, CHEM PHARM BULL, V39, P2357
[8]  
ODANI T, 1983, CHEM PHARM BULL, V31, P292
[9]  
ODANI T, 1983, CHEM PHARM BULL, V31, P1059
[10]  
ODANI T, 1983, CHEM PHARM BULL, V31, P3691